Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.36% is 185% above its 5-year average of -11.00%, near the high end of its 5-year range (-48.52%–11.25%).
24.90% above its 12-month average of 7.49%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 6.33%.
OPERATING MARGIN
9.36%
OPERATING MARGIN AVG TTM
7.49%
OPERATING MARGIN AVG 3Y
-0.82%
OPERATING MARGIN AVG 5Y
-11.00%
OPERATING MARGIN AVG 10Y
-11.29%
OPERATING MARGIN AVG 15Y
-23.03%
OPERATING MARGIN AVG 20Y
-103.33%
CURRENT VS TTM AVG
+24.90%
CURRENT VS 3Y AVG
+1240.74%
CURRENT VS 5Y AVG
+185.12%
CURRENT VS 10Y AVG
+182.92%
CURRENT VS 15Y AVG
+140.64%
CURRENT VS 20Y AVG
+109.06%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sanara MedTech Inc.
Market Cap
$321.85M
Operating Margin
9.36%
TTM Avg
7.49%
3Y Avg
-0.82%
5Y Avg
-11.00%
Market Cap
$322.64M
Operating Margin
-59.40%
TTM Avg
-73.74%
3Y Avg
-78.11%
5Y Avg
-79.89%
Market Cap
$324.76M
Operating Margin
-188.25%
TTM Avg
-178.83%
3Y Avg
-158.00%
5Y Avg
-158.00%
Market Cap
$318.43M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
Market Cap
$329.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$330.19M
Operating Margin
-65.36%
TTM Avg
-64.13%
3Y Avg
-75.36%
5Y Avg
-72.00%
Market Cap
$311.90M
Operating Margin
-18.00%
TTM Avg
-67.22%
3Y Avg
-104.89%
5Y Avg
-90.63%
Market Cap
$309.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6360.33%
5Y Avg
-12157.15%
Market Cap
$343.51M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.85M | 9.36% | 7.49% | -0.82% | -11.00% |
| Avita Medical Inc. (RCEL)vs › | $322.64M | -59.40% | -73.74% | -78.11% | -79.89% |
| CapsoVision, Inc. (CV)vs › | $324.76M | -188.25% | -178.83% | -158.00% | -158.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | -290.68% | -313.41% | -428.31% | -345.79% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -65.36% | -64.13% | -75.36% | -72.00% |
| Agenus Inc. (AGEN)vs › | $311.90M | -18.00% | -67.22% | -104.89% | -90.63% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | 0.00% | 0.00% | -6360.33% | -12157.15% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $343.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $295.38M | -144.71% | -144.71% | -144.71% | -144.71% |
Gross Margin
91.3%
Operating Margin
9.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 6.33% |
| 2026-03-31 | 9.52% |
| 2025-12-31 | 10.50% |
| 2025-09-30 | 11.25% |
| 2025-06-30 | -0.12% |
| 2025-03-31 | 3.52% |
| 2024-12-31 | -1.43% |
| 2024-09-30 | -8.88% |
| 2024-06-30 | -14.31% |
| 2024-03-31 | -8.26% |
| 2023-12-31 | -1.28% |
| 2023-09-30 | -5.66% |
| 2023-06-30 | -11.85% |
| 2023-03-31 | -7.84% |
| 2022-12-31 | -20.39% |
| 2022-09-30 | -24.78% |
| 2022-06-30 | -35.00% |
| 2022-03-31 | -35.55% |
| 2021-12-31 | -48.52% |
| 2021-09-30 | -31.83% |
| 2021-06-30 | -16.35% |
| 2021-03-31 | -21.63% |
| 2020-12-31 | -17.79% |
| 2020-09-30 | -30.35% |
| 2020-06-30 | -36.39% |
| 2020-03-31 | -50.96% |
| 2019-12-31 | -43.62% |
| 2019-09-30 | -27.40% |
| 2019-06-30 | -10.71% |
| 2019-03-31 | -6.32% |
| 2018-12-31 | -983.56% |
| 2018-09-30 | -8.43% |
| 2018-06-30 | 1.37% |
| 2018-03-31 | 3.40% |
| 2017-12-31 | -1.64% |
| 2017-09-30 | -1.86% |
| 2017-06-30 | 8.17% |
| 2017-03-31 | 3.63% |
| 2016-12-31 | 15.85% |
| 2016-09-30 | 15.34% |
| 2016-06-30 | -71.85% |
| 2016-03-31 | 12.68% |
| 2015-12-31 | -55.67% |
| 2015-09-30 | -14.57% |
| 2015-06-30 | -46.06% |
| 2015-03-31 | -9.47% |
| 2014-12-31 | -34.35% |
| 2014-09-30 | -95.34% |
| 2014-06-30 | -138.10% |
| 2014-03-31 | -60.62% |
| 2013-12-31 | -418.08% |
| 2013-09-30 | -70.10% |
| 2013-06-30 | -66.30% |
| 2013-03-31 | -107.57% |
| 2012-12-31 | -688.31% |
| 2012-09-30 | -482.90% |
| 2012-06-30 | -160.74% |
| 2012-03-31 | -212.28% |
| 2011-12-31 | -350.93% |
| 2011-09-30 | -561.74% |
| 2011-06-30 | -337.08% |
| 2011-03-31 | -50.89% |
| 2010-12-31 | -168.23% |
| 2010-09-30 | -852.33% |
| 2010-06-30 | -538.29% |
| 2010-03-31 | -688.99% |
| 2009-12-31 | -1551.25% |
| 2009-09-30 | -230.13% |
| 2009-06-30 | -338.53% |
| 2009-03-31 | -883.91% |
| 2008-12-31 | -1106.37% |
| 2008-09-30 | -466.66% |
| 2008-06-30 | -287.52% |
| 2008-03-31 | -563.57% |
| 2007-12-31 | -271.52% |
| 2007-09-30 | -51.63% |
| 2007-06-30 | 9.16% |
| 2007-03-31 | -172.93% |
| 2006-12-31 | -272.82% |
| 2006-09-30 | -265.53% |
| 2006-06-30 | -255.76% |
| 2006-03-31 | -243.80% |
| 2005-12-31 | -234.25% |
| 2005-09-30 | -189.48% |
| 2005-06-30 | -798.45% |
| 2005-03-31 | -301.45% |
| 2004-12-31 | -469.58% |
| 2004-09-30 | -18261.50% |
| 2004-06-30 | -365.01% |
| 2004-03-31 | -694.06% |
| 2002-03-31 | 0.00% |
| 2001-12-31 | 71.37% |
| 2001-09-30 | -101.17% |
| 2001-06-30 | -20.67% |
| 2001-03-31 | 5.01% |
| 2000-12-31 | -70.69% |
